skip to content
Pathophysiology and pharmacology of erythropoietin Preview this item
ClosePreview this item

Pathophysiology and pharmacology of erythropoietin

Author: Horst Pagel; Christoph Weiss; Wolfgang Jelkmann
Publisher: Berlin ; New York : Springer-Verlag, ©1992.
Edition/Format:   Print book : Conference publication : EnglishView all editions and formats

This work contains a series of about 40 articles reflecting the state-of-the-art of the pathophysiology and pharmacology of erythropoietin. Results from both basic research and clinical studies are  Read more...


(not yet rated) 0 with reviews - Be the first.

More like this

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...


Genre/Form: Kongress (Lübeck)
Conference papers and proceedings
Additional Physical Format: Online version:
Pathophysiology and pharmacology of erythropoietin.
Berlin ; New York : Springer-Verlag, ©1992
Material Type: Conference publication
Document Type: Book
All Authors / Contributors: Horst Pagel; Christoph Weiss; Wolfgang Jelkmann
ISBN: 3540547770 9783540547778 0387547770 9780387547770
OCLC Number: 25869713
Description: xv, 328 pages : illustrations ; 25 cm
Contents: List of Contents.- I. Structure and Action.- Structure-Function Relationships of Erythropoietin.- Isoforms of Recombinant Human Erythropoietin.- Activation of the Erythropoietin Receptor in the T3C12 Friend Erythroleukemia Cell Line.- II. Sites and Control of Production.- The Role of Adenosine in Hypoxic Regulation of Kidney Production of Erythropoietin.- Oxygen Shunt Diffusion in Renal Cortex and Its Physiological Link to Erythropoietin Production.- Oxygen Sensing and Erythropoietin mRNA Production in Isolated Perfused Rat Kidneys.- Analysis of Erythropoietin Gene Expression by Means of Competitive Polymerase Chain Reaction.- The Developmental Biology of Erythropoiesis and Erythropoietin: Is Erythropoietin a True Hormone or a Paracrine Factor.- Insulin-like Growth Factor 1 and Erythropoiesis During Growth.- III. Blood Levels in Health and Disease.- Clinical Applicability of the Determination of Erythropoietin.- A Sensitive ELISA for Erythropoietin and Its Application in Various Diseases.- Use of Erythropoietin Radioimmunoassay in Polycythemias.- Effects of Exercise on Plasma Erythropoietin in Natives Living Permanently at High Altitude.- Erythropoietin Concentration in Renal Venous Blood in Patient with Renovascular Hypertension: Is It a Marker of Renal Ischemia.- Serum Erythropoietin Levels in Von Hippel-Lindau Syndrome.- IV. Erythropoietin Replacement in Renal Failure.- Iron Metabolism Under Treatment of Renal Anemia with Recombinant Human Erythropoietin.- Erythropoietin Treatment in Children with Renal Anemia.- Bone Marrow Erythroid Precursor Cytoplasmic Ca2+ and 1, 25-Dihydroxyvitamin D3 Regulate the Response to Human Recombinant Erythropoietin in Uremia: In Vitro and In Vivo Studies.- Dyserythropoietic Abnormalities in Hemodialysis Patients on Long-Term Therapy with Human Recombinant Erythropoietin.- Cardiological Findings in Patients with End-Stage Renal Failure Under Treatment with Erythropoietin.- Long-Term Treatment with Recombinant Human Erythropoietin in Haemodialysis Patients: Effects on Left Ventricular Performance.- Retinal Hypoxia and Anemia in Chronic Renal Failure: Effect of Erythropoietin.- Experience with Subcutaneous Versus Intravenous Administration of Erythropoietin in Haemodialysis Patients.- Pharmacodynamic Aspects of Recombinant Human Erythropoietin - Long-Term Results in Patients with Hemodialysis Treatment.- Comparison of Three Routes of Administration of Recombinant Human Erythropoietin Expressed in C-127 Mouse Cells.- Peritoneal Permeability in Continuous Ambulatory Peritoneal Dialysis After the Correction of Anemia by Erythropoietin.- V. Primary Hemopoietic Disorders and Chemotherapy.- Serum Erythropoietin Levels in Aplastic Anemia Determined by ELISA.- Serum Erythropoietin in Myelodysplasia Syndromes.- Antigenic Characteristics of Erythropoietin-Dependent and -Independent Erythroid Progenitors in Chronic Myeloproliferative Disorders Defined by Monoclonal Antibodies.- Chemotherapy and Erythropoietin Production.- Production of Erythropoietin During and After Thiamphenicol Treatment Occurs Independently of Peripheral Blood Cell Numbers.- VI. Application of Recombinant Erythropoietin in Non-Renal Anemia.- Effects of Inflammatory Cytokines on the Production of Erythropoietin.- The Use of Recombinant Human Erythropoietin in the Treatment of the Anemia of Chronic Disorders.- Recombinant Human Erythropoietin in the Treatment of Anaemia in Rheumatoid Arthritis.- Erythropoietin in Neoplastic Diseases: Preliminary Results.- Erythropoietin Effects on Acute Anemia Induced by Antineoplastic Therapy in the Case of a Uremic Patient with Lymphoma.- The Therapeutic Effect of Recombinant Human Cytokines (GM-CSF, Interleukin-3, Erythropoietin) in Patients with Myelodysplasia Syndromes.- The Effect of Erythropoietin in Chemotherapy-Induced Anaemia in Patients with Osteosarcoma and Ewing's Sarcoma.- Erythropoietin in Bone Marrow Transplantation: Pathophysiology and Clinical Use.- Experimental and Clinical Results of Perioperative Treatment with Recombinant Human Erythropoietin.
Responsibility: Horst Pagel, Christoph Weiss, Wolfgang Jelkmann (eds.).


User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...


Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data

Primary Entity

<> # Pathophysiology and pharmacology of erythropoietin
    a schema:Book, schema:CreativeWork ;
    library:oclcnum "25869713" ;
    library:placeOfPublication <> ; # New York
    library:placeOfPublication <> ;
    library:placeOfPublication <> ; # Berlin
    schema:about <> ; # Anemia--drug therapy
    schema:about <> ; # Anämie
    schema:about <> ; # Chronische Niereninsuffizienz
    schema:about <> ; # Erythropoietin--Pathophysiology
    schema:about <> ; # Kongress
    schema:about <> ; # Renal anemia--Chemotherapy
    schema:about <> ; # Erythropoietin--physiology
    schema:about <> ;
    schema:about <> ; # Recombinant erythropoietin--Therapeutic use
    schema:about <> ; # Rekombinantes Protein
    schema:about <> ; # Recombinant erythropoietin--Pathophysiology
    schema:about <> ; # Recombinant Proteins--therapeutic use
    schema:about <> ; # Humans
    schema:about <> ; # Pharmakologie
    schema:about <> ; # Kidney Failure, Chronic--drug therapy
    schema:about <> ; # Anemia--Chemotherapy
    schema:about <> ; # Pathophysiologie
    schema:about <> ; # Lübeck
    schema:about <> ; # Erythropoietin--therapeutic use
    schema:bookFormat bgn:PrintBook ;
    schema:contributor <> ; # Wolfgang Jelkmann
    schema:contributor <> ; # Christoph Weiss
    schema:contributor <> ; # Horst Pagel
    schema:copyrightYear "1992" ;
    schema:datePublished "1992" ;
    schema:exampleOfWork <> ;
    schema:genre "Kongress (Lübeck)"@en ;
    schema:genre "Kongreß"@en ;
    schema:genre "Congress"@en ;
    schema:genre "Conference publication"@en ;
    schema:genre "Conference papers and proceedings"@en ;
    schema:inLanguage "en" ;
    schema:isSimilarTo <> ;
    schema:name "Pathophysiology and pharmacology of erythropoietin"@en ;
    schema:productID "25869713" ;
    schema:publication <> ;
    schema:publisher <> ; # Springer-Verlag
    schema:workExample <> ;
    schema:workExample <> ;
    umbel:isLike <> ;
    wdrs:describedby <> ;

Related Entities

<> # New York
    a schema:Place ;
    schema:name "New York" ;

<> # Springer-Verlag
    a bgn:Agent ;
    schema:name "Springer-Verlag" ;

<> # Anemia--drug therapy
    a schema:Intangible ;
    schema:name "Anemia--drug therapy"@en ;

<> # Chronische Niereninsuffizienz
    a schema:Intangible ;
    schema:name "Chronische Niereninsuffizienz"@en ;

<> # Erythropoietin--physiology
    a schema:Intangible ;
    schema:name "Erythropoietin--physiology"@en ;

<> # Erythropoietin--therapeutic use
    a schema:Intangible ;
    schema:hasPart <> ;
    schema:name "Erythropoietin--therapeutic use"@en ;
    schema:name "Erythropoietin--Therapeutic use"@en ;

<> # Kidney Failure, Chronic--drug therapy
    a schema:Intangible ;
    schema:name "Kidney Failure, Chronic--drug therapy"@en ;

<> # Recombinant erythropoietin--Pathophysiology
    a schema:Intangible ;
    schema:hasPart <> ;
    schema:name "Recombinant erythropoietin--Pathophysiology"@en ;

<> # Recombinant erythropoietin--Therapeutic use
    a schema:Intangible ;
    schema:hasPart <> ;
    schema:name "Recombinant erythropoietin--Therapeutic use"@en ;

<> # Recombinant Proteins--therapeutic use
    a schema:Intangible ;
    schema:name "Recombinant Proteins--therapeutic use"@en ;

<> # Rekombinantes Protein
    a schema:Intangible ;
    schema:name "Rekombinantes Protein"@en ;

<> # Wolfgang Jelkmann
    a schema:Person ;
    schema:birthDate "1949" ;
    schema:familyName "Jelkmann" ;
    schema:givenName "Wolfgang" ;
    schema:name "Wolfgang Jelkmann" ;

<> # Horst Pagel
    a schema:Person ;
    schema:familyName "Pagel" ;
    schema:givenName "Horst" ;
    schema:name "Horst Pagel" ;

<> # Christoph Weiss
    a schema:Person ;
    schema:familyName "Weiss" ;
    schema:givenName "Christoph" ;
    schema:name "Christoph Weiss" ;

    a schema:ProductModel ;
    schema:isbn "0387547770" ;
    schema:isbn "9780387547770" ;

    a schema:ProductModel ;
    schema:isbn "3540547770" ;
    schema:isbn "9783540547778" ;

    a schema:CreativeWork ;
    rdfs:label "Pathophysiology and pharmacology of erythropoietin." ;
    schema:description "Online version:" ;
    schema:isSimilarTo <> ; # Pathophysiology and pharmacology of erythropoietin

Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.